Table 1.
Antibiotic susceptibility patterns of MDR bacteria isolated from different types of wounds infected with pathogenic bacteria.
| Bacteria No. | Patients’ number and wound type | Type of bacteria |
Antibiotic susceptibility pattern |
|
|---|---|---|---|---|
| Sensitive | Resistant | |||
| 1 | (1) Hernia surgical wound | G-ve | Ak. | Am. /CL., Cef., Lev., Norf., Ofl., Peni.,Strept., Amp. |
| 2 | (1) Hernia surgical wound | G-ve | Am./Cl., Cef., Lev., Norf., Ofl., Peni., Strept., Amp., Ak. | |
| 3 | (2) Traumatic wound | G+ve | Am./Cl., Norf., Peni., Amp., Ak. | Cef., Lev., Ofl., Strept. |
| 4 | (3) Burn wound | G-ve | Lev., Ofl., Strept., Amp., Ak. | Am./Cl.,Cef., Norf., Peni. |
| 5 | (4) Traumatic wound | G-ve | Am./Cl., Cef., Lev., Norf., Ofl., Amp. | Peni., Strept. Ak. |
| 6 | (5) Caesarean section wound | G-ve | Lev., Ofl., Peni., Strept., Amp.,Ak. | Am./Cl., Cef., Norf. |
| 7 | (6) Surgical wound | G-ve | Cef., Lev., Norf., Ofl., Peni., Amp., Ak. | Am./Cl.,Strept. |
| 8 | (7) Surgical wound | G+ve | Cef., Lev., Norf., Amp., Ak. | Am./Cl., Ofl., Peni., Strept. |
| 9 | (8) Diabetic foot ulcer | G-ve | Ak. | Am./Cl., Cef., Lev., Norf., Ofl., Peni., Strept., Amp. |
| 10 | (9) Diabetic foot ulcer | G-ve | Lev., Norf. | Am./Cl., Cef., Ofl., Peni., Strept., Amp., Ak. |
| 11 | (9) Diabetic foot ulcer | G+ve | Am./Cl., Cef., Lev., Ofl., Strept., Amp., Ak. | Norf., Peni. |
| 12 | (10) Surgical wound | G-ve | Lev., Norf., Peni., Ak. | Am./Cl., Cef., Ofl., Strept., Amp. |
| 13 | (11) Traumatic wound | G+ve | Norf. | Am./Cl., Cef., Lev., Ofl., Peni., Strept., Amp., Ak. |
| 14 | (11) Traumatic wound | G-ve | Cef., Lev., Norf., Peni., Strept. | Am./Cl., Ofl., Amp., Ak. |
| 15 | (12) Surgical wound | G-ve | Cef., Lev., Norf., Ofl. Peni., Strept.,Amp. | Am./Cl., Ak. |
| 16 | (12) Surgical wound | G+ve | Cef., Lev., Norf., Ofl., Peni., Amp. | Am./Cl., Strep., Ak. |
| 17 | (13) Diabetic foot ulcer | G-ve | Am./Cl., Cef., Lev., Norf., Strept., Ak. | Ofl., Peni., Amp. |
| 18 | (14) Burn wound | G+ve | Am./Cl., Cef., Lev., Norf., Peni., Strept., Ak. | Ofl., Amp. |
| 19 | (14) Burn wound | G-ve | Am./Cl., Lev., Peni., Strept., Ak. | Cef., Norf., Ofl., Amp. |
| 20 | (14) Burn wound | G+ve | Am./Cl., Norf., Ofl., Peni., Amp., Ak. | Cef., Lev., Strept. |
| 21 | (15) Diabetic foot ulcer | G-ve | Am./Cl., Cef., Lev., Ofl., Strept., Amp., Ak. | Norf., Peni. |
| 22 | (15) Diabetic foot ulcer | G+ve | Cef., Lev., Ofl., Peni., Strept., Ak. | Am./Cl., Norf., Amp. |
Am./Cl. (Amoxicillin/clavulanic acid) (30 µg), Cef. (Cefoperazone) (75 µg), Lev. (Levofloxacin) (5 µg), Norf. (Norfloxacin) (10 µg), Ofl. (Ofloxacin) (5 µg), Peni. (Penicillin) (10 µg), Strept. (Streptomycin) (10 µg), Amp. (Ampicillin) (10 µg), Ak. (Amikacin) (30 µg).